Trial intelligence / Profile preview

Miglitol calcium vs nateglinide in type 2 diabetes

CTR20131966Phase 2Active

Sponsor
Shandong Chengchuang Pharmaceutical Technology Development
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of miglitol in type 2 diabetes mellitus (T2DM), sponsored by Shandong Chengchuang Pharmaceutical Technology Development. Started Mar 2014; status: active.

02

Drugs

miglitol
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on CTR20131966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call